ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Gynaecological cancers in the era of fertility preservation: old problems, novel approaches

6 May 2020
Guest Editor: Valentina Lucia La Rosa

Gynecological cancers in the era of fertility preservation: old problems, novel approaches

Valentina Lucia La Rosa

Unit of Psychodiagnostics and Clinical Psychology, University of Catania, Via Santa Sofia 78, 95123 Catania, Italy

Email address:

Gynaecological cancers are estimated to account for around 17-19% of new cancer cases diagnosed worldwide and their management is a challenge both in women of childbearing age and in elderly women [1,2]. About 21% of women receive a diagnosis of gynaecological cancer under the age of 40 and therefore of reproductive age [3-5]. Another important fact to take into account is that the first pregnancy is now more and more distant in time; consequently, many women get cancer before they become mothers for the first time [4].

Besides this, the different treatment options available have a significant impact on a woman's fertility. Indeed, on the one hand, the surgical management of ovarian, cervical and endometrial cancers requires a radical approach which often consists of hysterectomy and bilateral oophorectomy [6-8]; on the other hand, chemotherapy and radiotherapy may severely decrease ovarian reserve [9,10].

Thanks to the progress made over the years in the field of gynaecological oncology, the survival rate has significantly increased and, therefore, ensuring an adequate quality of life for patients has become a top priority for clinicians [3,11]. In this regard, it is important to consider that the psychological well-being of women is strongly affected by the experience of gynaecological cancer and its treatments [12,13]. Indeed, it has been widely documented how the potential loss of fertility may be for the woman a source of distress comparable to cancer itself [11,14]. To confirm this, many of these patients report high levels of depression and anxiety, suicidal ideation, feelings of anger and shame, low self-esteem, and a poor quality of life [4]. Furthermore, the treatments which the woman must undergo are not without side effects that also alter the body image, with inevitable repercussions on psychological functioning as well as on sexuality [10,15,16].

In this scenario, the perspective of becoming a mother after cancer may significantly improve compliance with treatments and recovery times, and consequently, fertility preservation has fundamental importance for women with gynaecological cancer [3,4,11,14].

Several fertility preservation techniques are available today but the choice of the most suitable one should take into account many factors, such as diagnosis, age of the woman, presence of a partner, financial resources, and time factor [17,18]. To date, fertility-sparing surgery has made great progress and breaks new ground for fertility preservation in patients with gynaecological cancer [19-22]. Embryo cryopreservation, requiring in vitro fertilisation and a male partner, seems to be the most effective fertility preservation technique. In cases of patients who do not require surgical treatment of fertility but undergoing adjuvant therapy with radiation therapy, ovarian transposition and cryopreservation of oocytes or embryos are the preferred treatments [23,24].

According to the literature about this topic, patients need to discuss fertility issues with their clinician and adequate fertility preservation counselling reduces distress and improves satisfaction levels and quality of life [4,11-13].

In light of all these considerations, this Special Issue aims to offer a comprehensive and multidisciplinary overview of the fertility-sparing surgical techniques, oocytes and ovarian tissue conservation and preservation of reproductive function in this particular kind of population. Also, space has been given to the discussion of the psychological implications of gynaecological cancer with particular reference to the impact of fertility preservation counselling and fertility preservation techniques on the quality of life of patients.

Conflicts of interest

No conflicts of interest to declare.


No funding was obtained for this study.


1. Bray F, Ferlay J, Soerjomataram I et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68,394-424

2. Vitale SG, Capriglione S, Zito G et al. (2019) Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition. Arch Gynecol Obstet 299,299-315

3. Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS (2017) The Importance of Fertility Preservation Counseling in Patients with Gynecologic Cancer. J Reprod Infertil 18,261-263

4. La Rosa VL, Shah M, Kahramanoglu I et al. (2019) Quality of life and fertility preservation counseling for women with gynecological cancer: an integrated psychological and clinical perspective. J Psychosom Obstet Gynaecol,1-7

5. Vitale SG (2019) The biopsy snake grasper sec. VITALE: a new tool for office hysteroscopy. J Minim Invasive Gynecol

6. Bellia A, Vitale SG, Laganà AS et al. (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294,615-622

7. Vitale SG, Marilli I, Lodato M, Tropea A, Cianci A (2013) The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review. Updates Surg 65,265-270

8. Lachance JA, Darus CJ, Rice LW (2008) Surgical management and postoperative treatment of endometrial carcinoma. Rev Obstet Gynecol 1,97-105

9. Laganà AS, Sofo V, Vitale SG, Triolo O (2016) Epithelial ovarian cancer inherent resistance: May the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? Gynecol Oncol Rep 18,57-58

10. Stabile C, Gunn A, Sonoda Y, Carter J (2015) Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer. Transl Androl Urol 4,169-185

11. Laganà AS, La Rosa VL, Rapisarda AM, Platania A, Vitale SG (2017) Psychological impact of fertility preservation techniques in women with gynaecological cancer. Ecancermedicalscience 11,ed62

12. Letourneau JM, Ebbel EE, Katz PP et al. (2012) Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 118,1710-1717

13. Lawson AK, Klock SC, Pavone ME et al. (2015) Psychological Counseling of Female Fertility Preservation Patients. Journal of psychosocial oncology 33,333-353

14. Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS (2018) Fertility preservation in women with gynaecologic cancer: the impact on quality of life and psychological well-being. Hum Fertil (Camb) 21,35-38

15. Carter J, Stabile C, Gunn A, Sonoda Y (2013) The physical consequences of gynecologic cancer surgery and their impact on sexual, emotional, and quality of life issues. J Sex Med 10 Suppl 1,21-34

16. Carter J, Huang H, Chase DM et al. (2012) Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 Study. Int J Gynecol Cancer 22,1624-1633

17. Woodard TL, Hoffman AS, Covarrubias LA et al. (2018) The Pathways fertility preservation decision aid website for women with cancer: development and field testing. J Cancer Surviv 12,101-114

18. Komatsu H, Yagasaki K, Yamauchi H (2018) Fertility decision-making under certainty and uncertainty in cancer patients. Sex Reprod Healthc 15,40-45

19. Vitale SG, Rossetti D, Tropea A, Biondi A, Laganà AS (2017) Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives. Updates Surg 69,29-34

20. Chiofalo B, Palmara V, Laganà AS et al. (2017) Fertility Sparing Strategies in Patients Affected by Placental Site Trophoblastic Tumor. Curr Treat Options Oncol 18,58

21. Liu D, Cai J, Gao A, Wang Z, Cai L (2020) Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival. BMC Cancer 20,320

22. Nezhat C, Roman RA, Rambhatla A, Nezhat F (2020) Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: a systematic review. Fertil Steril 113,685-703

23. Mahajan N (2015) Fertility preservation in female cancer patients: An overview. J Hum Reprod Sci 8,3-13

24. Del-Pozo-Lerida S, Salvador C, Martinez-Soler F et al. (2019) Preservation of fertility in patients with cancer (Review). Oncol Rep 41,2607-2614


Special Issue Articles

Valentina Lucia La Rosa, Simone Garzon, Giuseppe Gullo, Michele Fichera, Giovanni Sisti, Pasquale Gallo, Gaetano Riemma, Antonio Schiattarella
Suleiman Ghunaim, Ghina Ghazeeri, Dalia Khalife, Hatem A Azim Jr
Barbara Buonomo, Roberto Orecchia, Federica Tomao, Lino Del Pup, Alex Garcia-Faura, Fedro A Peccatori
Mattia Maramai, Fabio Barra, Mario Valenzano Menada, Sara Stigliani, Melita Moioli, Sergio Costantini, Simone Ferrero
Milan Terzic, Melanie Norton, Sanja Terzic, Gauri Bapayeva, Gulzhanat Aimagambetova